Óscar Millet

CEO at Atlas Molecular Pharma

Óscar is currently Group Leader at the Structural Biology Unit of the CIC bioGUNE, has published 55 papers and has in-depth expertise in the use of nuclear magnetic resonance (NMR) for the study of biologically relevant proteins and enzymes and has been central to the development of technology for the discovery of pharmacological chaperones and the exploration of new therapeutic intervention lines against different Rare Diseases including Congenital Erythropoietic Porphyria (CEP).

Links

Timeline

  • CEO

    Current role